Pneuma Respiratory Stock

Pneuma Respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery.

Sign up today and learn more about Pneuma Respiratory Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Pneuma Respiratory Stock

Pneuma Respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery. It has created PNEUMAHALER, the first fully integrated digital breath activated inhaler. The inhaled delivery system has integrated Bluetooth technology to provide feedback on drug delivery to patients, family members and health care providers. Using Pneuma's digital droplet ejector technology, Pneuma's device, although currently available for investigational purposes only, has the potential to ultimately deliver a spectrum of novel therapies, including biologics, through the lungs. Pneuma Respiratory was founded in 2015 and is headquartered in Boone, North Carolina, United States.

Funding History

July 2018$8.3M
August 2018$10.0M
July 2019$5.0M

Management

CEO

Eric Hunter

CSO

Jack Hebrank

Director of Asia

Chao Ping Lee

Board Member

Walter Robb

Board Member

Wei Zheng

Board Member

Douglas Stoner

Board Member

J. Singleton

Chair Of The Board Of Directors

Jay Morgan

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo